According to FutureWise analysis the market for GI stool testing in 2023 is US$ 1.03 billion, and is expected to reach US$ 1.6 billion by 2031 at a CAGR of 7.1%.
The analysis of faeces or stool samples to diagnose intestinal infections or diseases is known as GI stool testing. Bowel inflammation, malabsorption, and cancer are all examples of GI disorders. The growing prevalence of GI diseases due to junk food consumption, hectic lifestyles, and an ageing population is driving growth in the GI stool testing market. This population is conditioned to gastrointestinal infections. Furthermore, both the public and private sectors are expected to increase their investments in the healthcare sector, which is expected to drive market growth.
The vast majority of studies show a connection between gut health and overall health. The impacts of nutrition and other factors on health, including digestive, immunological, metabolic, and neuroendocrine processes, are mediated by the gut microbiota in particular. Using the right methods to assess GI health can assist practitioners in identifying the underlying causes of chronic illness. For instance, SDNA tests, commonly referred to as FIT-DNA tests, look for traces of DNA (genetic material) secreted by polyps and/or colon cancers rather than hiding the blood. The most popular stool test for this kind of screening is Cologuard. The Cologuard test can identify blood in a stool sample and ten other factors linked to colon cancer.
Request a Free Sample @ https://www.futurewiseresearch.com/healthcare-market-research/GI-Stool-Testing/3640
Gastrointestinal (GI) Stool Testing Market Segmentation:
By Product Type
- Reagents
- Instruments
By Application
- Colorectal Cancer
- Diarrhea
- GI Tract Infections
- Others (Poor Absorption Problems, Parasites)
By Test
- Microscopy Test
- Ova & Parasites Test
- Culture Test
- Bacteria Test
- Occult Blood test
- Guaiac FOB Stool Test
- Immuno-FOB agglutination test
- Lateral Flow Immuno-FOB Test
- Immuno-FOB ELISA Test
- Stool Biomarkers Tests
- Cologuard
- M2-PK Stool Test
- Others
By End User
- Hospitals
- Diagnostic Centres and Laboratories
- Academic Institutions
- Research Centres & Organizations
- Home
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Competitive Landscape in Gastrointestinal (GI) Stool Testing Market:
- Abbott Laboratories
- Alere
- Beckman Coulter
- BioMrieux
- Bio-Rad Laboratories
- Cenogenics Corporation
- DiaSorin
- Meridian Bioscience
- Quest Diagnostics Incorporated
- Siemens Healthcare
Ask For Discount: https://www.futurewiseresearch.com/contact.aspx?rpt=3640%20&type=discount
**Objectives of this Study: **
- To provide a comprehensive analysis of the Gastrointestinal (GI) Stool Testing Market By Product Type, By Application, By Test, By End User and By Region.
- To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
- To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
- To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Flexible Delivery Model:
- We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
- The customization services offered are free of charge with the purchase of any license of the report.
- You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com
FutureWise Research
Contact Person: Vinay Thaploo.
Email: sales@futurewiseresearch.com
Contact Number: Asia: +91 8605575209 | USA: +1 3477094931
Website: www.futurewiseresearch.com
